raremaprare-disease reference indexOrphadata 2026-06-23 · HPO 2026-09-01
ORPHA:101082

Charcot-Marie-Tooth disease type 1B

Synonyms: CMT1B

Type
Disease
Group
Disorder
Inheritance
Autosomal dominant
Age of onset
Adolescent, Adult, Childhood, Infancy
Status
active

Charcot-Marie-Tooth disease type 1B (CMT1B) is a form of CMT1, caused by mutations in the <i>MPZ</i> gene (1q22), that presents with the manifestations of peripheral neuropathy (distal muscle weakness and atrophy, foot deformities and sensory loss). The phenotype is variable depending on the particular mutation. Two distinct presentations have been described: (1) an early infantile onset severe phenotype with delayed walking and motor nerve conduction velocities (MNCV) <10 m/s, often referred to as Dejerine-Sottas syndrome, or (2) a much later onset phenotype (>age 40), with normal or mildly slowed MNCV and more frequent hearing loss and pupillary abnormalities. CMT1B can also cause the classical CMT phenotype in about 15% of total CMT1B cases.

1

Names in Orphadata languages

12 of 12 languages
LangNameSynonyms
enCharcot-Marie-Tooth disease type 1BCMT1B
frMaladie de Charcot-Marie-Tooth type 1B= en
deCharcot-Marie-Tooth-Krankheit Typ 1B= en
esEnfermedad de Charcot-Marie-Tooth tipo 1B
itMalattia di Charcot-Marie-Tooth, tipo 1B= en
nlZiekte van Charcot-Marie-Tooth type 1B= en
ptDoença de Charcot-Marie-Tooth tipo 1B
plChoroba Charcota, Mariego i Tootha typu 1B= en
csCharcotova-Marieova-Toothova nemoc, typ 1BCMT1B · Charcot-Marie-Toothova nemoc, typ 1B
ukХвороба Шарко-Марі-Тута, тип 1B= en
zh夏科-马里-图斯病1B型= en
trCharcot-Marie-Tooth hastalığı tip 1B= en

Definition in:

2

Cross-references

qualifier = Orphanet mapping relation
SourceCodeQualifierICD relationValidation
OMIM118200Evalidated
ICD-10G60.0NTBTattributedvalidated
ICD-118C20.0NTBTindexvalidated
MONDO0007307Evalidated
UMLSC0270912Evalidated

E exact · NTBT this ORPHAcode is narrower than the target · BTNT broader than the target · ND not decided.

3

Classification

Preferential parent (Orphanet linearisation):

Parents in the classifications (1):

No children.

4

Genes

1 direct
GeneAssociationStatusHGNCEnsemblOMIMLocusNameSource of validation
MPZDisease-causing germline mutation(s) inAssessedHGNC:7225ENSG000001588871594401q23.3myelin protein zero20301384[PMID]
5

Prevalence and incidence

1 record
TypeClassValueAreaQualificationValidationSource
Point prevalence1-9 / 100 000—WorldwideClass onlyValidatedORPHANET_20301384[PMID]

Value is Orphadata's ValMoy: the mean estimate per 100 000 for prevalence and incidence, the number of cases or families for case reports.

6

HPO phenotypes

14 annotations · validated 2018-07-20
HPOTerm (as annotated by Orphanet)Diagnostic
Very frequent (99-80%)
HP:0001324Muscle weakness
Frequent (79-30%)
HP:0000615Abnormal pupil morphology
HP:0001284Areflexia
HP:0000762Decreased nerve conduction velocity
HP:0003236Elevated circulating creatine kinase concentration
HP:0000365Hearing impairment
HP:0002922Increased CSF protein concentration
HP:0003477Peripheral axonal neuropathy
HP:0003469Peripheral dysmyelination
HP:0002650Scoliosis
HP:0003202Skeletal muscle atrophy
HP:0003712Skeletal muscle hypertrophy
Occasional (29-5%)
HP:0001270Motor delay
HP:0003474Somatic sensory dysfunction

Run the differential on the 1 obligate / very frequent terms

Annotation source: 12477701[PMID]_14711881[PMID]_18337304[PMID]

7

Sources for this card